deltatrials
Not Yet Recruiting INTERVENTIONAL NCT07542821

Cancer Survivors' Fear of Cancer Recurrence (MHPII)

Development and Evaluation of An Innovative Program in Mental Health Promotion

Sponsor: Koo Foundation Sun Yat-Sen Cancer Center

Updated 1 time since 2026 Last updated: Apr 14, 2026 Started: Apr 15, 2026 Primary completion: May 31, 2028 Completion: Nov 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07542821, this observational or N/A phase trial focuses on Fear of Cacer Recurrence in Cancer Survivorws and remains actively recruiting participants. Sponsored by Koo Foundation Sun Yat-Sen Cancer Center, it has been updated 1 time since 2026, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Apr 21, 2026 – present · 3 months · daily APINot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting [daily]

Eligibility Summary

The purpose of this study is to develop and evaluate the tailored support for the fear of cancer recurrence in breast, head and neck, colon-rectal or prostate cancer survivors. Based on screening for fear of cancer recurrence, different levels of supportive care will be provided, starting with the oncology nurses' health education and information for those having a lower level of concern. Those who have medium or higher levels of concerns will be randomized to receive "stepping up" either a "ConquerFear psychological cognitive training" or a "healthy lifestyle - individualized exercise and nutrition guidance".

Contact Information

Sponsor contact:
  • Koo Foundation Sun Yat-Sen Cancer Center
  • Ministry of Health and Welfare, Taiwan
  • National Taipei University of Nursing and Health Sciences
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.